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Abstract
Background: The aim of this study was to evaluate the effectiveness of two diagnostic tests routinely used for
diagnosing carpal tunnel syndrome (CTS)—ultrasonography (US) and nerve conduction studies (NCS)—by comparing
their accuracy based on surgical results, with the remission of paresthesia as the reference standard.
Methods: We enrolled 115 patients, all of the female gender with a high probability of a clinical diagnosis of CTS. All
patients underwent US and NCS for a diagnosis and subsequent surgical treatment. As a primary outcome, the accuracy
of the US and NCS diagnoses was measured by comparing their diagnoses compared with those determined by the
surgical outcomes. Their accuracy was secondarily evaluated based on before and after scores of the Boston Carpal
Tunnel Questionnaire (BCTQ).
Results: Overall, 104 patients (90.4%) were diagnosed with CTS by the surgical reference standard, 97 (84.3%) by NCS, and
90 (78.3%) by US. The concordance of NCS and surgical treatment (p < 0.001; kappa = 0.648) was superior to that of US
and surgical treatment (p < 0.001; kappa = 0.423). The sensitivity and specificity of US and NCS were similar (p = 1.000 and
p = 0.152, respectively: McNemar’s test). The BCTQ scores were lower after surgery in patients diagnosed by both US and
NCS (p < 0.001and p < 0.001, respectively: analysis of variance).
Conclusions: US and NCS effectively diagnosed CTS with good sensitivity but were not effective enough to rule out a
suspicion of CTS.
Trial registration: This study was registered at September, 10 th, 2015, and the registration number was NCT02553811.
Keywords: Carpal tunnel syndrome, Diagnostic accuracy, Diagnostic practices, Clinical diagnosis, Surgical treatment,
Ultrasonography, Ultrasound, Nerve conduction studies, Electrodiagnostic testing, Electromyograph
Background
Carpal tunnel syndrome (CTS), characterized by com-
pression of the median nerve at the wrist level, is the
most common compressive neuropathy of the upper
limb [1, 2]. Ultrasonography (US) and nerve conduction
studies (NCS) are diagnostic tests routinely used to con-
firm the diagnosis of CTS [3, 4]. As the parameters of
US and NCS have not been standardization for this diag-
nosis, and the cutoff point for a CTS diagnosis has not
been established, the diagnostic accuracy values for both
tests vary widely in the literature. These variations could
be related to different study designs, sample sizes, and
reference standards that do not reflect routine clinical
practice [1, 2]. Thus, the diagnosis of CTS is inconsistent
and controversial, with no universally accepted reference
standard [5, 6].
Well-designed primary CTS studies of methodological
quality sufficient to guide diagnostic practices are
uncommon and challenging [7–10]. Hence, we propose
a strategy for diagnosing CTS in routine clinical practice.
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It includes a methodological resource, based on an algo-
rithm, that could help obtain answers to the question of
what is the best pathway to an accurate diagnosis of
CTS. This study aimed to evaluate the effectiveness of
two diagnostic tests routinely used for diagnosing CTS
by comparing the accuracy of US and NCS with the re-
sults of the surgical treatment for the CTS. Remission of
paresthesia following surgery was the reference standard.
Methods
Ethical approval, registration, guidelines and study design
The ethics and research committees of Federal Univer-
sity of São Paulo/Paulista School of Medicine, São Paulo,
Brazil (approval No. 244468) and Paraiba Valley Regional
Hospital and Taubaté University Hospital, University of
Taubaté, Taubaté, Brazil (No. 009/13) approved this
study. It was registered in “ClinicalTrials.gov” (No.
NCT02553811) and followed the recommendations of
the STARD [11]. It is a primary, longitudinal, prospect-
ive clinical trial to determine accuracy performed at a
single center.
Participants and eligibility criteria
Initially were evaluated 173 participants with a clinical
suspicion of CTS. All participants who agreed to partici-
pate in this study signed the informed consent form and
underwent an initial clinical evaluation by the same
specialist in hand surgery. According to the sample
calculation, it was necessary to include a total of 115
eligible patients.
Probability of the clinical diagnosis: CTS-6 model
The CTS-6 [5], represents a logistic regression model
that estimates the diagnostic probability of CTS. “See
Additional file 1: Table S6”. A total score ≥ 12 was con-
sidered to indicate a high probability of a clinical diagno-
sis of CTS. There are six criteria for the probability of a
clinical diagnosis (CTS-6), with their respective scores
evaluated based clinical history and physical examination
on the patient’s initial clinical evaluation.
1. Paresthesia: in the territory of distribution of the
median nerve of the affected hand during any
period of the day and when performing manual
tasks (3.5 points)
2. Night paresthesia: in the territory of distribution of
the median nerve of the affected hand during sleep
or in the morning upon awakening (4.0 points)
3. Weakness and hypotrophy or atrophy of the tenar
musculature: loss of strength needed to grasp
objects, dropping them; evaluated by testing the
tenar musculature with the thumb in opposition
(5.0 points)
4. Tinel test: performed by applying digital percussion
in the anatomical path of the median nerve at wrist
level; test is positive when the patient reports a
sensation of “shock” at the percussion site that
irradiates to the territory of distribution of the
median nerve in the affected hand (4.0 points)
5. Phalen test: performed by the positioning the wrist
and elbow at 90° of flexion for 30–60 s; test is
positive when the patient reports the onset or
exacerbation of paresthesia in the territory of
distribution of the median nerve of the affected
hand (5.0 points)
6. Discrimination of sensory stimuli applied between
two points: performed by applying at least 10
cutaneous sensorial stimuli using a discriminator
instrument positioned longitudinally in the digital
pulp of the indicators, not in direct view of the
patient; test is positive when the patient does not
identify at least 7 of the 10 discriminator stimuli
placed at intervals of ≤6 mm (4.5 points)
Inclusion and exclusion criteria
Inclusion criteria were a CTS-6 score of ≥12 points, fe-
male gender, aged 40–80 years, unilateral or bilateral
Table 1 Distribution of patients by US and NCS results in relation to results of surgical treatment
Parameter Surgical treatment Total
No remission of paresthesia (CTS absent) Remission of paresthesia (CTS present)
N % n % N %
US 11 9.6 104 90.4 115 100.0
CSA < 10 mm2 (CTS absent) 9 7.8 16 13.9 25 21.7
CSA ≥10 mm2 (CTS present) 2 1.7 88 76.5 90 78.3
NCS 11 9.6 104 90.4 115 100.0
SCV ≥50 m/s and DML < 4.2 ms (CTS absent) 10 8.7 8 7.0 18 15.7
SCV < 50 m/s and DML ≥4.2 ms (CTS present) 1 0.9 96 83.5 97 84.3
n = 115 patients
Results are given as the total percent
CSA cross sectional area, CTS carpal tunnel syndrome, NCS nerve conduction studies, DML distal motor latency, US ultrasonography, SCV sensory
conduction velocity
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involvement (only a more symptomatic hand was con-
sidered for inclusion), previous conservative treatment
for CTS without clinical improvement. Exclusion criteria
were the presence of cervical radiculopathy, thoracic
outlet syndrome, pronator syndrome; a history of previ-
ous surgical release of the carpal tunnel, with sequelae
of fracture of the wrist; a CTS-6 score of ≤12 points;
lack of compliance at any stage of the study.
Diagnostic interventions
After the initial physical examination, eligible patients
underwent both US and NCS. These diagnostic inter-
ventions were performed in our institution, consecu-
tively and randomly on different days by the same
professional experts who were specialized and experienced
with US and NCS. They were unaware of the clinical situ-
ation of the patients at the time of the examination.
US
All US evaluations were performed on the same
equipment (model M2540A; Philips Healthcare, Both-
ell, WA USA) with high resolution and broadband
linear transducers, 4–6 MHz and 9–13 MHz. The US
examination technique consisted of positioning the
patient comfortably: sitting with the affected forearm
in a supine position in slight flexion and supported
on the examination table. The wrist is in neutral
position and the fingers in extension [12]. The object-
ive of US was to determine the cross-sectional area
(CSA) of the median nerve at the proximal limit (“in
let”) of the carpal tunnel by direct measurement. To
evaluate the diagnostic accuracy of US, an CSA value ≥10.
0 mm2 was the cutoff point to confirm a diagnosis of CTS
[3, 12–15].
NCS
All NCS was performed on the same equipment (model
MEB 9400 K, two channels; Nihon Kohden, Tokyo,
Japan). The NCS technique consisted of positioning the
patient comfortably in a horizontal dorsal decubitus
position with the upper limbs positioned at rest along
the body and prepared for a comparative assessment of
the muscular groups and the median, ulnar and radial
nerves, to exclude other conditions and differential diag-
noses [16–20]. The temperature of the upper limb to be
examined was acclimatized at 32 °C. The age and
temperature of the patients were considered in the diag-
nostic parameters of CTS by NCS evaluation [16]. The
objective of the NCS was to determine the sensory con-
duction velocity (SCV) of the median nerve in the third
finger–wrist segment for a length of 13 cm and the distal
motor latency (DML) of the median nerve from the
wrist to the tenar eminence. To evaluate the diagnostic
accuracy of NCS, the cutoff values to confirm a
Fig. 1 Comparison between observed, expected concordances and Kappa coefficient of the US and NCS
Table 2 Observed and expected concordances and Kappa coefficient for the comparisons between US, NCS and surgery
Comparison Observed concordance Expected concordance Kappa coefficient Standard error z p
US vs. surgery 84.4% 72.9% 0.423 0.083 5.08 < 0.001
NCS vs. surgery 92.2% 77.8% 0.648 0.090 7.22 < 0.001
US vs. NCS 76.5% 69.4% 0.232 0.091 2.54 0.006
NCS nerve conduction studies, US ultrasonography
There were 115 subjects in each comparison group
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diagnosis of CTS were < 50 m/s for SCV and ≥ 4.2 ms
for DML [3, 16–20].
Evaluation of the performance of diagnostic tests
Surgical treatment
After US and NCS had been performed, the patients
were forwarded and underwent to surgical treatment in
our institution, by one and the same surgeon. All patients
underwent intravenous regional Bier block anesthesia [21].
The surgical technique used was classic open release
through a palmar longitudinal incision about 2 cm in length
that did not extend proximally beyond the distal flexion
fold of the wrist or distally beyond the Kaplan line [22].
The patients were sent home on the same day and were
followed through the fourth postoperative month [23].
Primary outcome
Paresthesia remission after surgical treatment was
considered the reference standard for diagnosing CTS.
Patients with CTS who achieved paresthesia remission
postoperatively were considered truly affected by CTS,
and patients who did not experience remission were
considered not to have CTS [8]. The accuracy of the two
preoperative diagnostics methods was measured the
evaluating the US and NCS results (positive or negative)
relative to the results of the surgery (remission/no re-
mission of paresthesia) [9, 10].
Secondary outcome
The Boston Carpal Tunnel Questionnaire (BCTQ) is a
disease-specific (CTS) questionnaire that is self-
Fig. 2 Flowchart of the diagnostic intervention results
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administered and has been translated into the portu-
guese language and validated, which evaluates two com-
ponents: a scale of severity of symptoms and a scale of
functional status [24, 25]. All patients in this study
responded to two BCTQs: the first after the initial clin-
ical evaluation and the second at the end of the fourth
month of postoperative follow-up.
Statistical analysis
The categorical variables were presented as relative and
absolute frequencies, and numerical variables were
presented as a measures summary. The evaluation of the
observed and expected concordance between US and
NCS and the surgical treatment were performed using
the kappa coefficient. The accuracy of the US and NCS
relative to the paresthesia remission after surgical treat-
ment (reference standard) was evaluated using the
McNemar. Sensitivity, specificity, positive and negative
predictive values, and positive and negative likelihood
ratios were analyzed by statistical calculations of
expected values and obtained in a 2 × 2 contingency
table. The evolution of the BCTQ score by moments of
evaluation and diagnostic results was evaluated using
analysis of variance with repeated measures. For all
statistical tests, a significance level of 5% was adopted
[26]. The statistical package SPSS 20.0 (IBM Corp.,
Armonk, NY, USA) and Stata12 (Stata Corp., College
Station, TX, USA) software was used for the analyses.
The statistical sampling was performed considering a
20% difference between the sensitivity of the NCS and
US diagnostic tests using the McNemar test, with a stat-
istical power of 84.0% and a significance level of 5%. For
this calculation, we assumed as percentage of total
concordance the value of 60% and a prevalence of 80%
for STC, requiring a total sample of 115 patients [26].
Statistical software PASS 14 (Power Analysis and Sample
Size System; NCSS, https://www.ncss.com) was used.
Results
Study population
A total of 115 women were evaluated (average age ± SD
52.9 ± 9.1 years, range 40–79 years, median 52 years).
The average ± SD disease duration was 4.0 ± 3.2 years,
range 1–20 years, median 3 years. “See Additional file 2:
Table S7”.
Concordance between the diagnoses
Table 1 shows the total percentages of diagnoses of CTS
by the US and NCS relative to the total percentage of
diagnoses according to the surgical results (based on
remission, or not, of paresthesia). “See Additional file 3:
Table S8”.
As seen in Table 2, there was moderate concordance
between US and the surgical outcomes (p < 0.001, kappa
= 0.423), good concordance between NCS and the surgi-
cal outcomes (p < 0.001, kappa = 0.648), and reasonable
concordance between US and NCS (p = 0.006, kappa = 0.
232) (Fig. 1).
Accuracy of diagnostic tests
The results of the diagnostic interventions are summa-
rized in Fig. 2.
The sensitivity, specificity, and positive predictive
values for US (p = 1.000, McNemar test) and NCS (p = 0.
152, McNemar test) were similar, with no statistical
differences between the two diagnostic methods (Fig. 3).
The negative predictive values, however, were lower than
expected for both US and NCS. “Additional file 4: Table
Fig. 3 Interval confidence for sensitivity, specificity, positive and negative predictive value of the US and NCS
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S9, Additional file 5: Table S10, Additional file 6: Table
S11, Additional file 7: Table S12”. The positive and nega-
tive likelihood values were accurate and associated with
few false-positive and false-negative results for the cutoff
point considered and according to the reference stand-
ard used (Figs. 4 and 5). “Additional file 8: Table S13
and Additional file 9: Table S14 respectively, shows this
with more details”. The diagnostic accuracies for US and
NCS, according to the statistical parameters of this
study, are summarized in Table 3.
Assessment of severity of symptoms and functional
status
According to Tables 4 and 5, the mean symptom severity
score was reduced by 1.8 points and the functional sta-
tus score by 1.6 points on the second BCTQ, applied
4 months after surgery in patients with a CTS diagnosis
(Figs. 6, 7, 8 and 9).
Discussion
Well-designed studies that have focused on the diagno-
sis of CTS are uncommon. The deficiencies in the de-
sign of studies involving clinical and complementary
tests for CTS are associated with a super-estimation of
the performance of these diagnostic tests and the lack
of a universally accepted reference standard for diag-
nosing CTS [6, 8–10]. Most CTS diagnostic accuracy
studies were unlikely to report results that are applic-
able in clinical practice [1, 27]. The current study de-
sign followed an algorithm based on evaluating an
actual clinical practice routine for diagnosing CTS:
from the consecutive and random eligibility of patients
based on a high probability of a clinical diagnosis of
CTS, confirmed (or not) by US and NCS—performed
such that the examiners were unaware of the clinical
condition of the patients and the results of the concur-
rent complementary examination treatment follow-up
and its clinical outcomes. To ensure good diagnostic
accuracy it is important that the estimates provided by
a diagnostic test reflect its good performance in clinical
practice [1]. The remission of paresthesia (reference
standard) after surgical treatment was used in this
study to evaluate the effectiveness and performance of
the diagnosis of CTS by the US and NCS [3]. The clas-
sical open approach is considered a definitive surgical
treatment for CTS with good results in 75 to 90% of
patients [23]. In this study, 90.4% of the 115 operated
patients obtained remission of paresthesia with four
months pos operative, while in another study 78.9% of
the 113 operated patients obtained remission of
paresthesia with ten years pos operative by same surgi-
cal technique. [28]. As for the 9.6% of operated patients
who did not obtain remission of paresthesia with surgi-
cal treatment in our study, it can be attributed to prox-
imal compressions of the median nerve, double cervical
Table 3 Comparison of US and NCS: statistical values
Statistical parameter US NCS
Sensitivity(%) 84.6 (76.2–90.9) 92.3 (85.4–96.6)
Specificity(%) 81.8 (48.2–97.7) 90.9 (58.7–99.8)
Positive predictive value(%) 97.8 (92.2–99.7) 99.0 (94.4–100.0)
Negative predictive value(%) 36.0 (18.0–57.5) 55.6 (30.8–78.5)
Positive likelihood ratio(%) 4.7 (1.3–16.4) 10.2 (1.6–65.9)
Negative likelihoodratio(%) 0.2 (0.1–1.3) 0.1 (0–0.2)
NCS nerve conduction studies, US ultrasonography
Fig. 5 Confidence Interval for negative likelihood ratios (RV-) of the
US and NCS
Fig. 4 Confidence Interval for positive likelihood ratios (RV+) of the
US and NCS
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compression syndrome, cervical radiculopathy or even
to an advanced degree of CTS [22]. The evaluation of
the patients who did not obtain remission of
paresthesia after 4 months of the surgical treatment
was based on clinical criteria, using the parameters to
the CTS-6 and secondly BCTQ [1, 5, 24]. Though the
false-negative patients had normal (absent) results for
STC by US and NCS in this study, they were submitted
to surgical treatment, supported by the results obtained
by the clinical diagnosis for CTS in the initial clinical
evaluation. Patients with normal results (absent) for
CTS by the US showed better performance in the re-
mission of paresthesia after surgical treatment, as
shown in the Table 1. To obtain good quality of evi-
dence in this accuracy study, the degree of CTS impair-
ment provided by US and NCS was discarded and
reduced to a simple dichotomous (present / absent, ab-
normal / normal) diagnosis to make these tests useful
in clinical practice of routine [8, 9, 11]. The parameters
and cut-off points considered in this study for the diag-
nosis of CTS by the US and NCS had a direct impact
on the primary and secondary outcomes, producing the
four possible types of results of a diagnostic test, show-
ing balanced results for the values of accuracy,
especially between sensitivity and specificity. The posi-
tive results obtained by the kappa index in the evalu-
ation of NCS and US concordance in relation to the
reference standard in this study expressed the reliability
of these tests for the diagnosis of CTS, with NCS show-
ing a better performance. Mondelli et al. evaluated the
diagnostic usefulness of US and NCS in patients with a
clinical diagnosis of CTS and obtained positive kappa
values with good concordance [19]. The confirmation
of the clinical diagnosis of CTS in 90.4% of patients,
with a total of 84.3% for NCS and 78.3% for the US—
using remission of paresthesia as the reference stand-
ard—validated the CTS-6 clinical diagnostic probability
instrument used during the initial clinical evaluation.
Fowler et al. compared US and NCS using CTS-6 as a
reference standard and obtained results relative to con-
firmation of the clinical diagnosis of CTS in 65% of pa-
tients, relative to US diagnosis in 61%, and relative to
NCS diagnosis in 65% [29].
The sensitivity, specificity, and positive predictive
value of the US and NCS obtained in the current study
were similar, showing that both diagnostic methods were
effective for diagnosing CTS, with good sensitivity.
Well-designed diagnostic accuracy studies with STARD-
Table 5 BCTQ scores for functional status scale relative to CTS diagnosis by US and NCS
Parameter After treatment Before treatment Difference between after and before treatment
US
CSA≥ 10 mm2 (presence) 2.0 (0.9) 3.6 (0.9) −1.6 (1.1)
CSA < 10 mm2 (absence) 2.1 (0.9) 3.6 (1.0) −1.5 (1.1)
NCS
SCV < 50 m/s and DML ≥4.2 ms (presence) 2.0 (0.9) 3.6 (0.9) −1.6 (1.1)
SCV≥ 50 m/s and DML < 4.2 ms (absence) 2.3 (0.9) 3.7 (0.8) −1.5 (1.1)
n = 115 patients
Results are given as the mean (SD)
CSA cross sectional area, ANOVA analysis of variance, BCTQ Boston Carpal Tunnel Questionnaire, NCS nerve conduction studies, DML distal motor latency, US
ultrasonography, SCV sensory conduction velocity
ANOVA for repeated measurements—diagnostic effect: US (p = 0.634), NCS (p = 0.821)
ANOVA for repeated measures—effect of surgical treatment: US (p < 0.001), NCS (p < 0.001)
ANOVA for repeated measures—effect of interaction between diagnosis and surgical treatment: US (p = 0.629), NCS (p = 0.622)
Table 4 BCTQ scores for severity scale of symptoms relative to CTS diagnosis by US and NCS
Parameter After treatment Before treatment Difference between after and before treatment
US
CSA ≥10 mm2 (presence) 1.7 (0.7) 3.5 (0.7) −1.8 (0.9)
CSA < 10 mm2 (absence) 1.9 (0.8) 3.7 (0.8) −1.8 (1.0)
NCS
SCV < 50 m/s and DML ≥4.2 ms (presence) 1.7 (0.7) 3.5 (0.7) − 1.8 (0.9)
SCV ≥50 m/s and DML < 4.2 ms (absence) 2.1 (0.9) 3.7 (0.8) −1.6 (1.0)
n = 115 patients
Results are given as the mean (SD)
CSA cross sectional area, ANOVA analysis of variance, BCTQ Boston Carpal Tunnel Questionnaire, NCS nerve conduction studies, DML distal motor latency, US
ultrasonography, SCV sensory conduction velocity
ANOVA for repeated measurements—diagnostic effect: US (p = 0.135), NCS (p = 0.059)
ANOVA for repeated measures—effect of surgical treatment: US (p < 0.001), NCS (p < 0.001)
ANOVA for repeated measurements—effect of interaction between diagnosis and surgical treatment: US (p = 0.990), NCS (p = 0.246)
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compliant methodology obtained similar results when
comparing US and NCS [15, 29, 30]. Because of the low
negative predictive values, however, neither US nor NCS
could adequately rule out the clinical suspicion of CTS
in this study when compared with other studies with dif-
ferent reference standards [3, 29–32].
The reduced average of the two scores obtained with
the second BCTQ were statistically significant in the
current study, indicating improvement of the paresthesia.
Thus, the results of the surgical treatment in this study
were effective, according to the minimal clinical difference
proposed by Ozer et al. [33].
The main limitation of this study was that we did not
consider the degree of severity of the initial clinical and
complementary diagnosis of CTS. The two-point dis-
crimination test and atrophy of the thenar musculature
used in the CTS-6 model are directly linked to the se-
verity of CTS [34]. A value of > 13 mm2 for the median
nerve area found during US would correspond to a
moderate degree of impairment [35, 36]. Absence of a
Fig. 7 Evolution of the BCTQ score averages for symptom severity by nerve conduction studies
Fig. 6 Evolution of the BCTQ score averages for symptom severity scale by the ultrasonography
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sensory response and abnormal distal motor latency dur-
ing NCS would correspond to a severe degree of impair-
ment [3, 19].
Another limitation of this study was the inclusion of
only female patients, having the disadvantage of limiting
the generalization capacity of available information [10].
Conclusions
US and NCS were effective in the diagnosis of CTS,
showing a good sensitivity for the detection of patients
with CTS. The US and NCS did not show adequate
complementary exams to avoid the clinical suspicion of
CTS. The NCS presented better concordance regarding
the reference standard (remission of paresthesia) than
the US. The CTS-6 clinical diagnostic probability in-
strument was effective and validated for the suspected
cases of CTS, through the results obtained by the re-
duction of the means of the scores at the postoperative
in relation to the preoperative evaluated by the BCTQ.
The conclusions obtained by study will be useful for
areas that routinely handle the diagnosis-treatment
algorithm of CTS such as rheumatology, neurology,
neurosurgery and orthopedics. This accuracy clinical
trial provided further data regarding clinical diagnosis
and surgical treatment that may be useful in future
research.
Fig. 9 Evolution of the mean BCTQ scores for functional status by nerve conduction studies
Fig. 8 Evolution of the mean BCTQ scores for functional status by the ultrasonograph
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